Semaglutide for prevention of type 2 diabetes in women with postpartum prediabetes after gestational diabetes: protocol for a Belgian multicentre double-blind randomised placebo-controlled trial

Introduction Women with postpartum pre-diabetes following gestational diabetes mellitus (GDM) are at particularly high risk of developing type 2 diabetes mellitus (T2DM). While the implementation of effective lifestyle interventions in the early postpartum period is often difficult and has in genera...

Полное описание

Библиографические подробности

Главные авторы:	Annouschka Laenen, Chantal Mathieu, Katrien Benhalima, Ann Verhaegen, Yana Vanlaer, Nina Embo, Niels Bochanen, Nancy Van Wilder, Gertjan Vereecke, Katrien Wierckx, Peter Coremans, Jean-Christophe Philips, Maria Lytrivi, Philippe Oriot, Sara Vandewalle, Joke Cuypers, Barbara Deconinck
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMJ Publishing Group 2026-07-01
Серии:	BMJ Open
Online-ссылка:	https://bmjopen.bmj.com/content/16/7/e118191.full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!